Skip to main content
. 2014 Dec 30;6(5):2951–2965. doi: 10.18632/oncotarget.3095

Figure 5. CD44 and its related signaling pathways are involved in cell proliferation and cell cycle control.

Figure 5

(A-B) CD44 silencing inhibits cell proliferation (A) and downregulates PCNA and Ki67(B). (C-D) CD44 modulates cell cycle progression (C) and the expression of key cell cycle genes, Cyclin E2, Cyclin D1 and Cdk1(D). (E-F) Effects of PI3K inhibitor LY294002, AKT inhibitor MK-2206 and ERK inhibitor PD0325901 on CDK1 and its activity. *p<0.05.